Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

AEterna Zentaris (AEZS)

Add to Watchlists
Create an Alert
1.15 -0.02  -1.71% NASDAQ Apr 23, 3:10PM BATS Real time Currency in USD
View Full Chart
AEZS Price Chart
View All Events

AEZS Events

Date Type Description
Mar 21 Misc AEterna Zentaris, Inc. Q4 2013 Earnings Conference Call
Mar 20 Earnings AEterna Zentaris, Inc. Q4 2013 Earnings Results. Estimate: 0.03.
Nov 06 Misc AEterna Zentaris Q3 2013 Conference Call
Nov 05 Earnings AEterna Zentaris to Announce Third Quarter 2013 Financial Report. Estimate: -0.26.
Aug 09 Misc Aeterna Zentaris to Announce Second Quarter 2013 Financial Conference Call
Aug 08 Earnings AEterna Zentaris to Announce Second Quarter 2013 Financial and Operating Results on August 8, 2013. Estimate: -0.28.
May 08 Misc AGM Event for Aeterna Zentaris Inc.
May 07 Misc Aeterna Zentaris to Announce First Quarter 2013 Financial and Operating Results on May 7, 2013 and Hold Annual Shareholders Meeting on May 8, 2013
May 07 Earnings AEterna Zentaris to Announce First Quarter 2013 Financial and Operating Results on May 7, 2013 and Hold Annual Shareholders Meeting on May 8, 2013. Estimate: -0.29.
View All Performance Charts

AEZS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). AEterna Zentaris is down 34.66% over the last year vs S&P 500 Total Return up 22.69%, Actelion up 71.93%, and Jazz Pharmaceuticals up 161.6%.

Get Quote for
Advertisement

Portfolio Strategies Featuring AEZS

Did AEterna Zentaris make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

AEZS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: Canada
  • Headquarters State/Province: Quebec
  • Incorporation Country: Canada
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

AEterna Zentaris, Inc., is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology.

Recent Quotes

Symbol Price Chg Chg % Market Cap
AEZS 1.15 -0.02 -1.71% 64.76M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.